Two drugs significantly extend the time that women with metastatic breast cancer can live without their tumors growing, potentially changing the landscape for 80% of patients with the disease, according to two separate studies released Wednesday…"The magnitude of the impact seen in these trials is sufficient to incorporate the medicines in day-to-day practice," said Edith Perez, deputy director of the Mayo Clinic Comprehensive Cancer Center in Jacksonville, Fla., who wasn't directly involved in the studies.

Wall Street Journal, by Ron Winslow, 12/7/11

Additional coverage: Bloomberg/Businessweek, WebMD,

Tags: Breast Cancer, Breast Cancer, Cancer, Edith Perez, Mayo Clinic Jacksonville